← Back to Search

Treatment for Hepatitis C (EPIC Trial)

N/A
Waitlist Available
Led By Chris Fraser, MD
Research Sponsored by Cool Aid Community Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

EPIC Trial Summary

This trial looks at how well pharmacies can detect and treat hepatitis C.

Eligible Conditions
  • Hepatitis C

EPIC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HCV access to care for HCV testing and treatment

Find a Location

Who is running the clinical trial?

Cool Aid Community Health CentreLead Sponsor
Chris Fraser, MDPrincipal InvestigatorMedical Director
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Hepatitis C
100 Patients Enrolled for Hepatitis C

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there presently any open slots in this clinical experiment?

"Affirmative. The information available on clinicaltrials.gov shows that this trial is actively looking for participants, with the initial posting of it being on July 13th 2020 and its latest update occurring June 6th 2022. This study will involve 200 individuals from only one site."

Answered by AI

What is the upper threshold for patients participating in this experiment?

"Affirmative. Clinicaltrials.gov attests that this clinical trial, which was initially publicized on July 13th 2020, is now actively enrolling participants. The study seeks to recruit 200 patients from a single medical centre."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV
2020. "EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05412017.
~42 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top